Company news
SoftOx Solutions AS news in 2026
SoftOx Solutions AS's news releases, calls and decks from 2026, newest first.
SoftOx Solutions AS: SoftOx attracts renowned inhaled antimicrobial expert Dr. Bruce Montgomery to lead Clinical Advisory Board ahead of Phase 2b
September 29, 2026
SoftOx Solutions AS: Half Year Report 2026
September 23, 2026
SoftOx Solutions AS: FIRST PATIENT DOSED IN SIS-03 PROOF-OF-CONCEPT PATIENT TRIAL
August 11, 2026
SoftOx Solutions AS: POSITIVE TOPLINE SAFETY DATA FROM SIS-03 DOSE-ESCALATION PHASE
June 26, 2026
SoftOx Solutions AS: First Quarter Report 2026
June 24, 2026
SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited
June 9, 2026
SoftOx Solutions AS: SIS-03 DOSE-ESCALATION PHASE COMPLETED AND INITIATION OF PROOF-OF-CONCEPT PHASE
June 8, 2026
SoftOx Solutions AS: FIRST PARTICIPANT ENROLLED IN BIODEFENCE-FOCUSED SIS-02 PHASE 1 CLINICAL STUDY
June 5, 2026
SoftOx Solutions AS: Annual Report 2025
May 27, 2026
SoftOx Solutions AS: New Share Capital
April 21, 2026
SoftOx Solutions AS: Fourth Quarter Report 2025
March 25, 2026
SoftOx Solutions AS: First Subject Dosed in Combined Phase 2a Dose-Escalation and Proof-of-Concept Trial (SIS-03)
March 3, 2026